PMID: 35658024): The study showed mean weight reduction of 15.0% , 19.5% , 20.9% vs 3.1% placebo at 72 weeks The study showed up to 36% of participants achieved 25% or more weight loss with tirzepatide 15 mg Tirzepatide Once Weekly for the Treatment of Obesity in People with Type 2 Diabetes (SURMOUNT-2) , published in The Lancet (Garvey WT et al., 2023
Rare side effects of tirzepatide may include: Pancreatitis (inflammation of the pancreas) Gallbladder problems (gallstones and inflammation of the gallbladder) Severe abdominal pain or persistent vomiting If you experience symptoms of pancreatitis or gallbladder issues, stop the medication and consult with your healthcare provider to seek medical advice
Starting tirzepatide is not a quick fixits a medical decision that changes appetite signaling, digestion speed, and metabolic patterns
Before reviewing, I signed up with Lavender Sky Health, recorded the process, and gathered the key info you need to see if its a good fit
Meier JJ, Kemmeries G, Holst JJ, Nauck MA
